SCHEMBL7685154

SCHEMBL7685154

CC(=O)Nc1ccc(CCOC(C)=O)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 1/20 0.51
SMN1; SMN2 Q16637 2/20 0.50
TSHR P16473 2/20 0.50
HTT P42858 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPT P10636 3/20 0.49
KDM4E B2RXH2 2/20 0.49
NPSR1 Q6W5P4 1/20 0.49
HPGD P15428 1/20 0.49
RECQL P46063 1/20 0.49
ALDH1A1 P00352 3/20 0.49
TDP1 Q9NUW8 2/20 0.49
LMNA P02545 1/20 0.49
CYP1A2 P05177 1/20 0.49
CA12 O43570 1/20 0.48
BRD4 O60885 1/20 0.48
NR1I2 O75469 1/20 0.48
CA1 P00915 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8031664 0.87 ALDH1A1 (0.43) AOC3SMN1; SMN2MEN1KMT2AMAPT
SCHEMBL28396867 0.86 AOC3 (0.54) AOC3SMN1; SMN2TSHRHTTL3MBTL1
SCHEMBL8031654 0.84 ALDH1A1 (0.48) SMN1; SMN2L3MBTL1MEN1KMT2AMAPT
SCHEMBL29622963 0.83 AOC3 (0.67) AOC3SMN1; SMN2TSHRHTTL3MBTL1
SCHEMBL29622962 0.83 AOC3 (0.67) AOC3SMN1; SMN2TSHRHTTL3MBTL1
SCHEMBL2968894 0.82 MEN1 (0.63) SMN1; SMN2TSHRHTTL3MBTL1MEN1
SCHEMBL9815410 0.81 RAB9A (0.53) AOC3TSHRMEN1KMT2AMAPT
SCHEMBL5537937 0.80 AOC3 (0.49) AOC3SMN1; SMN2TSHRHTTL3MBTL1
SCHEMBL5537940 0.80 AOC3 (0.49) AOC3SMN1; SMN2TSHRHTTL3MBTL1
SCHEMBL11116153 0.80 SMN1; SMN2 (0.59) AOC3SMN1; SMN2TSHRHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025016273-A1 ISOQUINOLINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USES OF ISOQUINOLINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION 拜西欧斯(北京)生物技术有限公司 2025-01-23 WO disclosed
US-6342503-B1 ANTIDEPRESSANTS, EATING DISORDERS DUPONT PHARMACEUTICALS COMPANY 2002-01-29 US disclosed
US-6140051-A USE IN THE FIELD OF BIOLOGICAL ASSAYS PROMEGA BIOSCIENCES, INC. (US) 2000-10-31 US disclosed
US-6107301-A PSYCHOLOGICAL DISORDERS DUPONT PHARMACEUTICALS COMPANY (US) 2000-08-22 US disclosed
EP-1000042-A1 FLUORESCENT DIBENZAZOLE DERIVATIVES AND METHODS RELATED THERETO Promega Biosciences, Inc. (US) 2000-05-17 EP disclosed
WO-2000004007-A1 FLUORESCENT DIBENZAZOLE DERIVATIVES AND METHODS RELATED THERETO PROMEGA BIOSCIENCES, INC. (US) 2000-01-27 WO disclosed
WO-1999003849-A1 FLUORESCENT DIBENZAZOLE DERIVATIVES AND METHODS RELATED THERETO PROMEGA BIOSCIENCES, INC. (US) 1999-01-28 WO disclosed
EP-0723533-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-07-31 EP disclosed
WO-1995010506-A1 1N-ALKYL-N-ARYLPYRIMIDINAMINES AND DERIVATIVES THEREOF THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1995-04-20 WO disclosed
US-5225431-A Treatment of migraine BURROUGHS WELLCOME CO. (US) 1993-07-06 US disclosed
EP-0313397-B1 THERAPEUTIC HETEROCYCLIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1993-06-02 EP disclosed
EP-0313397-A1 Therapeutic heterocyclic compounds THE WELLCOME FOUNDATION LIMITED (GB) 1989-04-26 EP disclosed